CooperCompanies completes $1.6B acquisition of Generate Life Sciences, funded by $1.5B term loan

COOPER COMPANIES, INC.

Cooper completed acquisition of Generate Life Sciences for ~$1.605B in cash.
Generate provides donor egg/sperm, fertility cryopreservation, and newborn stem cell storage.
Acquisition funded by a $1.5B non-amortizing 5-year senior unsecured term loan.
Term loan matures Dec 17, 2026; bears interest at LIBOR + 75bps or base rate.
CooperSurgical adds Generate to strengthen fertility clinic and Ob/Gyn offerings.

item 1.01 item 2.01 item 2.03 item 7.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.